Alzheimers
disease
The term Alzheimer's disease refers to a condition
discovered by a doctor called Alois Alzheimer. In 1907 he wrote
in medical journals about a woman of 51 who had died of
dementia, whose brain he had examined under the microscope.
Memory
loss in Alzheimers disease
Memory loss occurs in all cases of Alzheimers, but in the
early stages it can be difficult to detect as people manage to
cover it up successfully. The most recent memories are the
first to go, and it's only much later as the Alzheimers
condition has become much more severe that the long term memory
is affected.
Disorientation and
Alzheimers Disease
Disorientation (or not knowing who or where you are or what
day month etc it is), is very common in Alzheimers
disease. It's also noted as one of the defining early
symptoms, and as it is very closely connected with a person's
memory or the ability to remember, it's what you might
expect.
Disorientation and Alzheimers
disease in the home
Disorientation inside the home can eventually become a
problem though not until much later in the disease.
Alzheimers Disease
and Personality
One of the most distressing aspects of Alzheimers disease is
the complete change of personality many people suffer. This is
especially distressing for their relatives and friends. The
personality and general behaviour of Alzheimer sufferers in the
later stages often seems to be in complete contrast to the
usual behaviour they have always exhibited in their previous
life.
Alzheimers disease
and Communication
Speech is frequently affected in Alzheimers disease. An
understanding of simple speech remains intact during the early
stages, but difficulties in finding and expressing the correct
words can appear very early on in the disease.
03/02/2010
Neuroimaging Technique Supports Reduction In Amyloid-Beta In Brains Of Patients Suffering From Alzheimer's Disease Treated With Bapineuzumab
Elan Corporation, plc (NYSE: ELN) announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer's disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology...
Neuroimaging Technique Supports Reduction In Amyloid-Beta In Brains Of Patients Suffering From Alzheimer's Disease Treated With Bapineuzumab
03/05/2010
Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer's Treatment
In an announcement today, Mount Sinai School of Medicine (MSSM) and Medisyn Technologies, Inc...
Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer's Treatment
03/09/2010
State Roundup: N.Y. Drug Pricing, Vermont Hospital Ads, Massachusetts Nursing Homes And Anti-Psychotics
Poughkeepsie Journal: A new report on New York drug prices, "issued by the New York Public Interest Research Group, Consumers Union, the Center for Medical Consumers and AARP, looked at the price of the 10 most popular drugs found in the state's pharmacies provided through a Freedom of Information Law request...
State Roundup: N.Y. Drug Pricing, Vermont Hospital Ads, Massachusetts Nursing Homes And Anti-Psychotics
03/09/2010
Alzheimer's Association Honors Social Security Commissioner Michael Astrue With Humanitarian Award
Social Security Commissioner Michael Astrue is the recipient of the Alzheimer's Association's 2010 Humanitarian Award. The award is given each year to a public official who has made a significant contribution to help those who are struggling with Alzheimer's disease...
Alzheimer's Association Honors Social Security Commissioner Michael Astrue With Humanitarian Award
*************************************
|